Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer.

被引：2
|
作者：
Takahari, Daisuke [1 ]
Wakatsuki, Takeru [1 ]
Mashima, Tetsuo [1 ]
Chin, Keisho [1 ]
Ichimura, Takashi [1 ]
Ogura, Mariko [1 ]
Matsushima, Tomohiro [1 ]
Osumi, Hiroki [1 ]
Nakayama, Izuma [1 ]
Ota, Yumiko [1 ]
Shinozaki, Eiji [1 ]
Suenaga, Mitsukuni [1 ]
Kawata, Naomi [1 ]
Horiike, Yuki [1 ]
Seimiya, Hiroyuki [1 ]
Fujita, Naoya [1 ]
Yamaguchi, Kensei [1 ]
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
81
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
    Ueda, Akira
    Yuki, Satoshi
    Ando, Takayuki
    Hosokawa, Ayumu
    Nakada, Naokatsu
    Kito, Yosuke
    Motoo, Iori
    Ito, Ken
    Sakumura, Miho
    Nakayama, Yurika
    Ueda, Yuko
    Kajiura, Shinya
    Nakashima, Koji
    Harada, Kazuaki
    Kawamoto, Yasuyuki
    Komatsu, Yoshito
    Yasuda, Ichiro
    CANCERS, 2024, 16 (05)
  • [42] A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Honda, Kazunori
    Asahina, Hajime
    Tamura, Yosuke
    Hozak, Rebecca R.
    Gao, Ling
    Suzukawa, Kazumi
    Enatsu, Sotaro
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (04) : 298 - 305
  • [43] Phase II trial of palbociclib in patients with advanced esophageal or gastric cancer.
    Karasic, Thomas Benjamin
    O'Hara, Mark H.
    Teitelbaum, Ursina R.
    Damjanov, Nevena
    Giantonio, Bruce J.
    d'Entremont, Tracy S.
    Gallagher, Maryann
    Zhang, Paul J.
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [44] CPT-11 is an active agent in patients with advanced gastric cancer.
    Köhne, CH
    Catane, R
    Klein, H
    Peretz, T
    Preusser, P
    Niederle, N
    Ducreux, M
    Wilke, H
    Jacques, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3773S - 3773S
  • [45] A retrospective analysis of third-line treatment in advanced gastric cancer.
    Ishizuka, Yasunobu
    Terazawa, Tetsuji
    Yukami, Hiroki
    Yamaguchi, Toshifumi
    Kuwakado, Shin
    Kii, Takayuki
    Goto, Masahiro
    Higuchi, Kazuhide
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [46] Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer
    Chung, Hyun Cheol
    Kok, Victor C.
    Cheng, Rebecca
    Hsu, Yanzhi
    Orlando, Mauro
    Fuchs, Charles
    Cho, Jae Yong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (03) : 204 - 209
  • [47] A serum microRNA biomarker panel for detection of gastric cancer.
    So, Jimmy
    Zou, Ruiyang
    Zhou, Lihan
    Too, Heng-Phon
    Zhu, Feng
    Teo, Yik Ying
    Yap, Celestial T.
    Rha, Sun Young
    Kono, Koji
    Yoong, Joanne
    Yeoh, Khay-Guan
    Yong, Wei-Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] CEACAM6, A Novel Biomarker in Gastric Cancer.
    Sivakumar, S.
    Pollock, S.
    Speirs, V
    Grabsch, H.
    JOURNAL OF PATHOLOGY, 2010, 222 : S18 - S18
  • [49] Safety of ramucirumab in patients with advanced gastric cancer in Europe and North America: A prospective observational registry.
    Silvestro, Lucrezia
    De Vita, Ferdinando
    Vogel, Arndt
    Ettrich, Thomas Jens
    Van Cutsem, Eric
    Di Bartolomeo, Maria
    D'yachkova, Yulia
    Liepa, Astra M.
    Smolyakova, Natalia
    Lukanowski, Mariusz
    Huang, Yu-Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 341 - 341
  • [50] A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
    Hiroshi Matsumoto
    Akihito Kawazoe
    Kaoru Shimada
    Shota Fukuoka
    Yasutoshi Kuboki
    Hideaki Bando
    Takashi Kojima
    Atsushi Ohtsu
    Takayuki Yoshino
    Toshihiko Doi
    Kohei Shitara
    BMC Cancer, 18
12345